CLINTON H. LEINWEBER D.O.

**** ********* *****, **********, ** 27834 cell 252-***-**** email adifn2@r.postjobfree.com Page 1 of 3 clinton h leinweber 111020.docx

EDUCATION

William Paterson University, Wayne, NJ

BA Biology 1980

University of Medicine and Dentistry of New Jersey, Newark, NJ D.O. 1984

UMDNJ Kennedy Memorial Hospital, Stratford, NJ

Internship 1984-1985

UMDNJ University Hospital, Newark, NJ

Resident Internal Medicine 1985-1987

UMDNJ University Hospital, Newark, NJ

Chief Medical Resident Internal Medicine 1987-1988 The Johns Hopkins University School of Medicine, Baltimore, MD Fellowship Radiation Oncology 1988-1991

BOARD CERTIFICATION / LICENSURE

North Carolina Medical Board License # 201*-*****-**** American Board of Radiology - Radiation Oncology 1995 American Board of Internal Medicine 1988

Maryland Medical Board License # 36554 1988

National Board of Medical Examiners for Osteopathic Physicians and Surgeons 1985 New Jersey Medical Board License # 49321 1984

WORK HISTORY

Staff Physician

Moonlight Medical

Raleigh, NC 08/2020-Present

Clinical Professor

Department Radiation Oncology

East Carolina University - Brody School of Medicine Greenville, NC 07/ 2012-06/2017

Director

Stereotactic Ablative Brain and Body Radiosurgery Program ECU-Vidant Medical Center

Greenville, NC 01/2014-08/2017

Co-Medical Director Clinical Trials Office

East Carolina University

Greenville, NC 01/2014-08/2017

Medical Director

Lehigh Valley Gamma Knife Center Lehigh Valley Hospital Allentown PA 07/2004-06/2012

Private Practice

Allentown Radiation Oncology Associates

Allentown PA 07/1991-08/2012

TEACHING EXPERIENCE

CLINTON H. LEINWEBER D.O.

Page 2 of 3 clinton h leinweber 111020.docx

Co-Director Medical Physics Residents Radiobiology course 2016-2017 East Carolina University, Greenville NC

Clinical Professor

Department Radiation Oncology

East Carolina University - Brody School of Medicine Greenville, NC 2012–2017

Clinical Assistant Professor 1997-2009

Penn State College of Medicine, Hershey PA

MEMBERSHIPS

Elekta Gamma Knife Society 2008

Society for Neuro-Oncology 2007

Neuro-Oncology Committee, North Central Cancer Treatment Group Mayo Clinic 2004 International Stereotactic Radiosurgery Society 1995 American Society for Therapeutic Radiology and Oncology 1988 American Medical Association 1986

American Osteopathic Association 1984

ADDITIONAL PROFESSIONAL TRAINING

CyberKnife Full Body Radiosurgery Training course

Accuray Training Center

Sunnyvale, CA 2012

Principles and Practice of Gamma Knife Radiosurgery / emphasis on Perfexion course University of Pittsburgh Center for Image Guided Neuosurgery Pittsburgh, PA 2011

Leksell Gamma Plan Advanced Training course

Elekta Training Center

Norcross, GA 2006

Principles and Practice of Gamma Knife Radiosurgery course University of Pittsburgh Center for Image Guided Neurosurgery Pittsburgh, PA 2004

Stereotactic guided precision radiotherapy using stereotactic body frame course Karolinska Institute

Stockholm, Sweden 2002

AWARDS / GRANTS

Co-Investigator

Highly Sensitive Raman Gas Spectroscopy of Exhaled Breath for Non-Invasive Detection of Lung Cancer

ECU Division of Research, Economic Development and Engagement 2016 Principal Investigator

C. Coach Rock Roggerman Cancer Research Fund

Investigating the potential of Civa Sheet Brachytherapy device in resectable pancreas cancer 2014

Burroughs Wellcome Osteopathic Research Fellowship 1985 The C. Kent Warner Award

CLINTON H. LEINWEBER D.O.

Page 3 of 3 clinton h leinweber 111020.docx

Department of Biology

William Paterson College of New Jersey 1980

Who’s Who Among Students in American Universities and Colleges William Paterson College of New Jersey 1979-1980

RECENT PUBLICATIONS

Articles

Ferreira C, Johnson D, Rasmussen K, Leinweber C, Salahuddin A, Jung JW A novel conformal superficial high-dose rate brachytherapy device for treatment of non-melanoma skin cancer and keloids. Brachytherapy 2017 16:1 215-222.

Harris KB, Corbett MR, Mascarenhas H, Lee KS, Hyder A, Leinweber C, Ju AW Single institution analysis of 126 patients treated with stereotactic radiosurgery for brain metastasis. Frontiers in Oncology - 2017 Vol. 7 1-6 Abstracts

Pinnamaneni R, Hedge AM, Cherukuri DS, Arastu HH, Bowling M, Leinweber C, Stroud CG, Cherry C, Walker PR Sequence of stereotactic ablative radiotherapy and immune checkpoint blockade in the treatment of metastatic lung cancer. J.Clin.Oncol. 2017 35 no.15 suppl. e20665

Barnes T, Harris EE, Hollowman M, Arastu HH, Leinweber C, Ju A, Naves J A quality verification tool to assure complete pre-treatment electronic medical records for patients undergoing radiation therapy. J.Clin.Oncol. 2017 35 no. 8 suppl. 103 Harris EE, Arastu HH, Leinweber C, Ju A, McLaurin R, Blackburn R, Shelton C, Barnes T, Holloman M Adoption of regional peer review program for radiation oncology. J.Clin.Oncol. 2017 35 no. 8 suppl. 67 Grinchak TA, Sokolovic C, Hollan B, Parent T, Cherukuri S, Bowling M, Arastu H, Leinweber C, Walker, P, Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int.J.Radiat.Oncol.Biol.Phys. 2016 Vol 96 suppl. 3491 Hildebrand, JR, Cherukuri S, Arastu HH, Leinweber C, Stroud CG, Parent T, Cherry C, Hardin J, Walker P Outcomes in patients with stage III non-small cell lung cancer treated with cis-platin and irinotecan with concurrent radiotherapy: A multi-disciplinary thoracic oncology experience at East Carolina University. J.Clin.Oncol. 2016 34 no. 5 suppl. e20019

Walker P, Rosenman J, Arastu H, Leinweber C, Aljumail R, Biswas T, Russo S, Parent T, Eubanks S Oligomestatic Non-Small Cell Lung Cancer Treated With Curative Intent - Int.J.Radiat.Oncol.Biol.Phys. 2016 Vol 96 suppl. 200

Cherukuri S, Walker P, Parent T, Ben-Or S, Moran J, Williams R, Arastu HH, Leinweber C ERCC-1 high stage IIb/III esophageal cancer treated with non-platinum based neoadjuvant or definitive chemoradiotherapy. J.Clin.Oncol. 2014 32 no. 15 suppl. e15047 Laack N, Galanis E, Leinweber C, Buckner J, Giannini C, Geoffroy FJ, Jaeckle GA, Sarkaria JN Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed Glioblastoma multiforme. J.Clin.Oncol. 2012 30 no.15 suppl. 2032

Contact this candidate